BR112015001782A2 - método para produzir uma composição para o tratamento de um dente lesionado - Google Patents

método para produzir uma composição para o tratamento de um dente lesionado

Info

Publication number
BR112015001782A2
BR112015001782A2 BR112015001782A BR112015001782A BR112015001782A2 BR 112015001782 A2 BR112015001782 A2 BR 112015001782A2 BR 112015001782 A BR112015001782 A BR 112015001782A BR 112015001782 A BR112015001782 A BR 112015001782A BR 112015001782 A2 BR112015001782 A2 BR 112015001782A2
Authority
BR
Brazil
Prior art keywords
composition
treating
produce
lesion
injured tooth
Prior art date
Application number
BR112015001782A
Other languages
English (en)
Inventor
Amadeus Lysek Domenikus
HUG Michael
Original Assignee
Credentis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Credentis Ag filed Critical Credentis Ag
Publication of BR112015001782A2 publication Critical patent/BR112015001782A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C5/00—Filling or capping teeth
    • A61C5/60—Devices specially adapted for pressing or mixing capping or filling materials, e.g. amalgam presses
    • A61C5/68—Mixing dental material components for immediate application to a site to be restored, e.g. a tooth cavity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C2205/00—Compositions applicable for the manufacture of vitreous enamels or glazes
    • C03C2205/06—Compositions applicable for the manufacture of vitreous enamels or glazes for dental use
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S522/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S522/908—Dental utility

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Dentistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

resumo “método para produzir uma composição para o tratamento de uma lesão dentária” a invenção se refere a um método para a preparação de uma composição para o tratamento de uma lesão dentária, a referida composição compreendendo peptídeos que são capazes de sofrer automontagem a um certa ph. as composições da invenção são altamente adequadas para serem usadas no campo da medicina, em particular para a remineralização de uma lesão dentária como uma lesão de cárie da subsuperfície. 2 1 / 1
BR112015001782A 2012-08-15 2013-08-14 método para produzir uma composição para o tratamento de um dente lesionado BR112015001782A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12180578.2A EP2698162A1 (en) 2012-08-15 2012-08-15 Method for producing a composition for treating a tooth lesion
PCT/EP2013/066962 WO2014027012A1 (en) 2012-08-15 2013-08-14 Method for producing a composition for treating a tooth lesion

Publications (1)

Publication Number Publication Date
BR112015001782A2 true BR112015001782A2 (pt) 2017-11-28

Family

ID=46982401

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001782A BR112015001782A2 (pt) 2012-08-15 2013-08-14 método para produzir uma composição para o tratamento de um dente lesionado

Country Status (9)

Country Link
US (2) US10047120B2 (pt)
EP (2) EP2698162A1 (pt)
JP (1) JP6518588B2 (pt)
CN (2) CN104684573A (pt)
BR (1) BR112015001782A2 (pt)
ES (1) ES2674159T3 (pt)
HK (1) HK1206998A1 (pt)
PL (1) PL2884991T3 (pt)
WO (1) WO2014027012A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2698162A1 (en) * 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
GB201600290D0 (en) 2016-01-07 2016-02-24 Fujifilm Diosynth Biotechnologies Uk Ltd Process
GB201600287D0 (en) * 2016-01-07 2016-02-24 Fujifilm Diosynth Biotechnologies Uk Ltd Process
EP3248591A1 (en) * 2016-05-24 2017-11-29 Credentis AG Method and product for caries treatment
EP3248590A1 (en) * 2016-05-24 2017-11-29 Credentis AG Personal dental care product for caries treatment
JP7094023B2 (ja) * 2016-08-16 2022-07-01 クレデンティス・アクチェンゲゼルシャフト 歯肉炎、歯周炎および／またはインプラント周囲炎の治療における使用のための自己組織化ペプチドを含む組成物
EP3284477A1 (en) * 2016-08-16 2018-02-21 Credentis AG Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis
US11377634B2 (en) 2016-11-07 2022-07-05 University Of Florida Research Foundation, Inc. 3D micro fabrication and screening
USD825741S1 (en) 2016-12-15 2018-08-14 Water Pik, Inc. Oral irrigator handle
KR102575843B1 (ko) 2017-02-02 2023-09-08 워어터 피이크, 인코포레이티드 치아 세정을 위한 연마제를 포함하는 정제
KR102625450B1 (ko) 2017-03-16 2024-01-16 워어터 피이크, 인코포레이티드 구강 작용제와 함께 사용하기 위한 구강 세척기 핸들
USD868243S1 (en) 2018-03-16 2019-11-26 Water Pik, Inc. Oral irrigator tip
EP3736574A1 (en) * 2019-05-07 2020-11-11 Atlas Antibodies AB A formulation comprising an isotope labeled fusion polypeptide
EP3763348A1 (en) * 2019-07-10 2021-01-13 Credentis AG Self-assembling peptides in the prevention and treatment of cavitated carious lesions
EP3831360A1 (en) * 2019-12-04 2021-06-09 Credentis AG Personal dental care product for preventing demineralisation
EP3984517A1 (en) * 2020-10-19 2022-04-20 Credentis AG Accelerating tooth remineralisation and bone regeneration with self-assembling peptides and amorphous calcium phosphate
CN114191597B (zh) * 2021-12-16 2022-11-25 湖南银华棠医药科技有限公司 一种皮肤创面修复用液体敷料及其制备方法和用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
IL161660A0 (en) 2004-04-29 2004-09-27 Medimop Medical Projects Ltd Liquid drug delivery device
US7399831B2 (en) 2004-10-25 2008-07-15 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
CA2592292A1 (en) 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of pdgf using self-assembling peptide nanofibers
EP3326647A1 (en) * 2005-06-17 2018-05-30 Regenerx Biopharmaceuticals, Inc. Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized
JP4766528B2 (ja) 2005-06-27 2011-09-07 株式会社メニコン 自己組織化ペプチドおよびそれより得られるゲル
JO3324B1 (ar) * 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
WO2008121447A1 (en) 2007-02-14 2008-10-09 Northwestern University Self-assembling membranes and related methods thereof
EP2146733B1 (en) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
WO2008150479A2 (en) * 2007-06-01 2008-12-11 Acologix, Inc. High temperature stable peptide formulation
CN101939329A (zh) 2007-08-30 2011-01-05 滑铁卢大学 以氨基酸配对为基础的自组装肽和方法
WO2010041636A1 (ja) 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤
DK2349314T3 (da) * 2008-10-21 2013-05-27 Baxter Int Lyofiliserede præparater af rekombinant VWF
GB0821806D0 (en) * 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
SG174857A1 (en) 2009-03-09 2011-11-28 Menicon Co Ltd Self-assembling peptide and peptide gel with high strength
MX2011008671A (es) * 2009-04-01 2011-09-06 Colgate Palmolive Co Composiciones dentifricas y metodos para el tratamiento y prevencion del deterioro de las superficies dentales.
IL202069A0 (en) 2009-11-12 2010-06-16 Medimop Medical Projects Ltd Fluid transfer device with sealing arrangement
US20110117195A1 (en) 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
EP2512399B1 (en) 2010-02-24 2015-04-08 Medimop Medical Projects Ltd. Fluid transfer assembly with venting arrangement
DK2512398T3 (da) 2010-02-24 2014-10-13 Medimop Medical Projects Ltd Overføringsindretning for flydende medikament med udluftet ampuladapter
EP2698162A1 (en) * 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion

Also Published As

Publication number Publication date
WO2014027012A1 (en) 2014-02-20
US20150232511A1 (en) 2015-08-20
US10464968B2 (en) 2019-11-05
US20180340010A1 (en) 2018-11-29
EP2884991B1 (en) 2018-03-21
CN104684573A (zh) 2015-06-03
PL2884991T3 (pl) 2018-09-28
HK1206998A1 (en) 2016-01-22
JP2015526438A (ja) 2015-09-10
EP2698162A1 (en) 2014-02-19
ES2674159T3 (es) 2018-06-27
US10047120B2 (en) 2018-08-14
CN110448677A (zh) 2019-11-15
JP6518588B2 (ja) 2019-05-22
EP2884991A1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
BR112015001782A2 (pt) método para produzir uma composição para o tratamento de um dente lesionado
CY1120670T1 (el) Μονοκλωνικα αντισωματα εναντι του αναστολεα μονοπατιου ιστικου παραγοντα (tfpi)
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1119410T1 (el) Βελτιστοποιημενα μονοκλωνικα αντισωματα εναντι του αναστολεα της οδου του ιστικου παραγοντα (tfpi)
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
MX343706B (es) Derivados heterocíclicos novedosos.
EA201491299A1 (ru) Карбаматные соединения, их получение и применение
MX2019010601A (es) Terapia de combinacion para tratar cancer.
UY32919A (es) Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
MX340452B (es) Novedosos derivados de purina y su uso en el tratamiento de enfermedades.
CY1116775T1 (el) Παραγωγα πυριμιδονης ως αναστολεις της ιστικης τρανσγλουταμινασης
MX2015004362A (es) Derivados de ketamina.
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
CY1115734T1 (el) Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη
CY1121238T1 (el) Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
CY1120395T1 (el) Παραγωγα στερολης και χρηση αυτων για την αγωγη νοσηματων που περιλαμβανουν μετασχηματισμενα αστροκυτταρα ή για την αγωγη κακοηθων αιμοπαθειων
BRPI0917245A8 (pt) Compostos derivados de isoquinolinona e sua composição farmacêutica
TR201004464A2 (tr) Kemik erimesi için formülasyon.
PH12014502065A1 (en) Vesicular formulations
UA117809C2 (uk) Похідні бендамустину, споріднені сполуки та їхнє медичне застосування для лікування раку
PH12015501251A1 (en) Compositions and methods for treating dental caries
BR112013000296A2 (pt) agentes terapêuticos 976
UA112981C2 (uk) Варіант людського gdnf

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements